Acta Scientific Ophthalmology (ISSN: 2582-3191)

Editorial Volume 6 Issue 4

Functional Diabetic Retinopathy: A Switch to Control Diabetes - Related Complications and Vision Loss

Bhim B Rai1,2*, Deepa Rai3 and Ted Maddess1

1John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia
2Ophthalmology Department, JDW National Referral Hospital, Thimphu, Bhutan
3Warrigal Aged Care Facility, Calwell, ACT, Australia

*Corresponding Author: Bhim B Rai, John Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.

Received: February 27, 2023; Published: March 01, 2023

Burden of diabetes

The International Diabetes Federation estimated the global prevalence of DM at 463 million in 2019 [1]. Diabetic retinopathy (DR) is a major complication and a leading cause of visual loss [2]. Among diabetics, global prevalence for DR was 19–25%, 6% for vision-threatening DR (VTDR), and 4% for diabetic macular oedema (DMO) [3]. In 2020, the number of adults worldwide with DR, VTDR, and DMO was estimated to be 103.1 million, 28.5 million, and 18.8 million, respectively [3]. By 2045, it is projected that there will be 700 million people with DM, 160.5 million with DR, 44.8 million with VTDR, and 28.6 million with DMO [1,3].

Keywords: Diabetic Retinal Neurodegeneration; Diabetic Retinopathy; Functional Diabetic Retinopathy; Perimetry; Retinal Sensitivity; Structure-Function Correlation

References

  1. Saeedi P., et al. “Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9 (th) edition”. Diabetes Research and Clinical Practice 157 (2019): 107843.
  2. Wang W and Lo ACY. “Diabetic Retinopathy: Pathophysiology and Treatments”. International Journal of Molecular Sciences 6 (2018).
  3. Teo ZL., et al. “Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045: Systematic Review and Meta-analysis”. Ophthalmology (2021).
  4. Lopes de Faria JM., et al. “Retinal nerve fibre layer loss in patients with type 1 diabetes mellitus without retinopathy”. British Journal of Ophthalmology 86 (2002): 725-728.
  5. van Dijk HW., et al. “Decreased retinal ganglion cell layer thickness in patients with type 1 diabetes”. Investigative Ophthalmology and Visual Science 7 (2010): 3660-3665.
  6. Parravano M., et al. “Functional Retinal Impairment in Type 1 Diabetic Patients without any Signs of Retinopathy”. Ophthalmic Research 2 (2013): 108-112.
  7. Picconi F., et al. “Retinal neurodegeneration in patients with type 1 diabetes mellitus: the role of glycemic variability”. Acta Diabetology 5 (2017): 489-497.
  8. Simó R and Hernández C. “Neurodegeneration in the diabetic eye: new insights and therapeutic perspectives”. Trends in Endocrinology and Metabolism 1 (2014): 23-33.
  9. Montesano G., et al. “Evidence for Structural and Functional Damage of the Inner Retina in Diabetes With No Diabetic Retinopathy”. Investigative Ophthalmology and Visual Science 3 (2021): 35.
  10. Rai BB., et al. “Comparing retinal thickness and Matrix 10-2 functional testing in diabetic macular edema”. Investigative Ophthalmology and Visual Science 7 (2020).
  11. Sabeti F., et al. “Multifocal pupillography identifies changes in visual sensitivity according to severity of diabetic retinopathy in type 2 diabetes”. Investigative Ophthalmology and Visual Science 8 (2015): 4504-4513.
  12. Rai BB., et al. “Comparing objective perimetry, matrix perimetry, and regional retinal thickness in mild diabetic macular edema”. Translational Vision Science and Technology 13 (2021): 32.
  13. Rai BB., et al. “Rapid objective testing of visual function matched to the ETDRS-grid, and its diagnostic power in AMD”. Ophthalmology Science 2 (2022): 1-9.

Citation

Citation: Bhim B Rai., et al. “Functional Diabetic Retinopathy: A Switch to Control Diabetes - Related Complications and Vision Loss".Acta Scientific Ophthalmology 6.4 (2023): 01-02.

Copyright

Copyright: © 2022 Bhim B Rai., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate35%
Acceptance to publication20-30 days
ISI- IF1.042
JCR- IF0.24

Indexed In




News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is May 30, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US